Renewable Energy

Pfizer to buy Array for $10.64 bln

Credit: REUTERS/Arnd Wiegmann

Pfizer Inc said on Monday it had agreed to acquire Array Biopharma Inc for $10.64 billion, which will grant it access to its cancer drugs. [nBw8NKHlFa]

June 17 (Reuters) - Pfizer Inc PFE.N said on Monday it had agreed to acquire Array Biopharma Inc ARRY.O for $10.64 billion, which will grant it access to its cancer drugs.

The cash deal for $48 per share of Array represents a premium of about 62% to the stock's closing price on Friday.

(Reporting by Tamara Mathias in Bengaluru; Editing by James Emmanuel)

((Tamara.Mathias@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 1208; Reuters Messaging: tamara.mathias.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More